Mesa Laboratories, Inc. (NASDAQ:MLAB) declared a quarterly dividend on Wednesday, October 3rd, Wall Street Journal reports. Stockholders of record on Friday, November 30th will be paid a dividend of 0.16 per share by the medical instruments supplier on Monday, December 17th. This represents a $0.64 annualized dividend and a dividend yield of 0.32%. The ex-dividend date is Thursday, November 29th.
Mesa Laboratories has increased its dividend payment by an average of 1.6% annually over the last three years. Mesa Laboratories has a payout ratio of 9.0% meaning its dividend is sufficiently covered by earnings. Research analysts expect Mesa Laboratories to earn $8.19 per share next year, which means the company should continue to be able to cover its $0.64 annual dividend with an expected future payout ratio of 7.8%.
Shares of MLAB opened at $202.37 on Friday. The company has a current ratio of 1.72, a quick ratio of 1.29 and a debt-to-equity ratio of 0.29. Mesa Laboratories has a 12-month low of $122.35 and a 12-month high of $224.95. The firm has a market cap of $773.38 million, a PE ratio of 45.72 and a beta of 0.27.
Several equities analysts have recently issued reports on MLAB shares. ValuEngine raised Mesa Laboratories from a “hold” rating to a “buy” rating in a research note on Tuesday, October 23rd. BidaskClub raised Mesa Laboratories from a “strong sell” rating to a “sell” rating in a research note on Thursday, October 18th. Finally, TheStreet lowered Mesa Laboratories from a “b-” rating to a “c” rating in a research note on Tuesday, August 21st.
In related news, Director Seg Ventures, Llc bought 20,000 shares of the business’s stock in a transaction on Sunday, December 30th. The shares were purchased at an average price of $23.10 per share, with a total value of $462,000.00. Following the completion of the purchase, the director now owns 120,000 shares of the company’s stock, valued at approximately $2,772,000. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Michael T. Brooks sold 2,700 shares of the stock in a transaction dated Monday, September 10th. The shares were sold at an average price of $195.39, for a total value of $527,553.00. Following the completion of the transaction, the director now directly owns 27,750 shares in the company, valued at approximately $5,422,072.50. The disclosure for this sale can be found here. Insiders acquired 90,000 shares of company stock worth $2,097,600 in the last three months. Insiders own 15.00% of the company’s stock.
TRADEMARK VIOLATION WARNING: This report was published by WKRB News and is the property of of WKRB News. If you are accessing this report on another publication, it was stolen and republished in violation of international copyright & trademark laws. The original version of this report can be viewed at https://www.wkrb13.com/2018/11/24/mesa-laboratories-inc-mlab-to-issue-quarterly-dividend-of-0-16-on-december-17th.html.
Mesa Laboratories Company Profile
Mesa Laboratories, Inc designs, manufactures, and markets quality control instruments and disposable products. The company's Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness.
Recommended Story: What are the most popular ETFs
Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.